Arrivent Biopharma, Inc. · NASDAQ:AVBP
BlackRock, Inc. reported a 5.60% stake in Arrivent Biopharma, Inc. (Schedule 13G)
Event Dec 31, 2025 · Filed Jan 21, 2026
BlackRock, Inc. reported a 5.60% stake in Arrivent Biopharma, Inc., 2,319,341 shares, as a passive investor on Dec 31, 2025. Filed Jan 21, 2026 (Schedule 13G).
- Stake
- 5.60%
- Shares
- 2,319,341
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 5.60% | 2,319,341 |
Source
Related
- Arrivent Biopharma, Inc.
- BlackRock, Inc.
- Arrivent Biopharma, Inc. shareholders
- Schedule 13G/A · BlackRock, Inc. · Jul 27, 2026
- Schedule 13G/A · BlackRock, Inc. · Oct 17, 2025
- Schedule 13G · Vivo Opportunity, LLC · Oct 13, 2026
- Schedule 13D/A · Orbimed Advisors LLC · Oct 8, 2026
- Schedule 13G/A · FMR LLC · May 6, 2026
- Schedule 13G/A · Sofinnova Venture Partners IX, L.P. ("SVP IX") · Mar 5, 2026
- Schedule 13G/A · Hillhouse Investment Management, Ltd. · Feb 17, 2026